{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:46:58Z","timestamp":1789962418514,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s12105-007-0033-2","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:16:48Z","timestamp":1196957808000},"page":"132-140","source":"Crossref","is-referenced-by-count":32,"title":["Bisphosphonate-related Osteonecrosis of the Jaws: An Update on Clinical, Pathological and Management Aspects"],"prefix":"10.1007","volume":"1","author":[{"given":"Giuseppe","family":"Ficarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Beninati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,5]]},"reference":[{"key":"33_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/02841860701233435","volume":"46","author":"S Wu","year":"2007","unstructured":"Wu S, Dahut WL, Gulley JL. The use of bisphosphonates in cancer patients. Acta Oncol 2007;46:581\u201391","journal-title":"Acta Oncol"},{"key":"33_CR2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","volume":"61","author":"J Wang","year":"2003","unstructured":"Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003;61:1104\u20137","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0278-2391(03)00566-4","volume":"61","author":"TJ Rosenberg","year":"2003","unstructured":"Rosenberg TJ, Ruggiero S. Osteonecrosis of the jaws associated with the use of bisphosphonates. J Oral Maxillofac Surg 2003;61:60 (letter)","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE. Marx","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61:1115\u20137 (letter)","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR5","first-page":"4253","volume":"21","author":"CA. Migliorati","year":"2003","unstructured":"Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. New Engl J Med 2003;21:4253\u20134 (letter)","journal-title":"New Engl J Med"},{"key":"33_CR6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, et\u00a0al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527\u201334","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjmed.2004.04.015","volume":"117","author":"G Lugassy","year":"2004","unstructured":"Lugassy G, Shaham R, Nemets A, et\u00a0al. Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 2004;117:440\u20131","journal-title":"Am J Med"},{"key":"33_CR8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","volume":"34","author":"JV Bagan","year":"2005","unstructured":"Bagan JV, Murillo J, Poveda R, et\u00a0al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 2005;34:120\u20133","journal-title":"J Oral Pathol Med"},{"key":"33_CR9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2005.05382.x","volume":"128","author":"AM Vannucchi","year":"2005","unstructured":"Vannucchi AM, Ficarra G, Antonioli E, et\u00a0al. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 2005;128:738 (letter)","journal-title":"Br J Haematol"},{"key":"33_CR10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","volume":"32","author":"G Ficarra","year":"2005","unstructured":"Ficarra G, Beninati F, Rubino I, et\u00a0al. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 2005;32:1123\u20138","journal-title":"J Clin Periodontol"},{"key":"33_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","volume":"104","author":"CA Migliorati","year":"2005","unstructured":"Migliorati CA, Schubert MM, Peterson DE, et\u00a0al. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005;104:83\u201393","journal-title":"Cancer"},{"key":"33_CR12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-0714.2005.00351.x","volume":"34","author":"E Merigo","year":"2005","unstructured":"Merigo E, Manfredi M, Meleti M, et\u00a0al. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four- case report. J Oral Pathol Med 2005;34:613\u20137","journal-title":"J Oral Pathol Med"},{"key":"33_CR13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.urology.2005.03.028","volume":"66","author":"KB Olson","year":"2005","unstructured":"Olson KB, Hellie CM, Pienta KJ. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid. Urology 2005;66:658","journal-title":"Urology"},{"key":"33_CR14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","volume":"134","author":"K Zervas","year":"2006","unstructured":"Zervas K, Verrou E, Teleioudis Z, et\u00a0al. Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients. Br J Haematol 2006;134:620\u20133","journal-title":"Br J Haematol"},{"key":"33_CR15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/annonc\/mdl163","volume":"17","author":"G Sanna","year":"2006","unstructured":"Sanna G, Preda L, Bruschini R, et\u00a0al. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Ann Oncol 2006;17:1512\u20136","journal-title":"Ann Oncol"},{"key":"33_CR16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","volume":"24","author":"A Badros","year":"2006","unstructured":"Badros A, Weikel D, Salama A, et\u00a0al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006;24:945\u201352","journal-title":"J Clin Oncol"},{"key":"33_CR17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"S-B Woo","year":"2006","unstructured":"Woo S-B, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144:753\u201361","journal-title":"Ann Intern Med"},{"key":"33_CR18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","volume":"7","author":"CA Migliorati","year":"2006","unstructured":"Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonates treatment. Lancet Oncol 2006;7:508\u201314","journal-title":"Lancet Oncol"},{"key":"33_CR19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","volume":"102","author":"SL Ruggiero","year":"2006","unstructured":"Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Pathol Oral Med 2006;102:433\u201341","journal-title":"Oral Surg Oral Pathol Oral Med"},{"key":"33_CR20","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1056\/NEJMp068157","volume":"355","author":"JP. Bilezikian","year":"2006","unstructured":"Bilezikian JP. Osteonecrosis of the jaw-Do bisphosphonates pose a risk? N Engl J Med 2006;355:2278\u201381","journal-title":"N Engl J Med"},{"key":"33_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncponc0688","volume":"4","author":"CR Dunstan","year":"2007","unstructured":"Dunstan CR, Felsenberg D, Seibel MJ. Therapy insight: the risk and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nature Clin Pract Oncol 2007;4:42\u201355","journal-title":"Nature Clin Pract Oncol"},{"key":"33_CR22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3174\/ajnr.A0518","volume":"28","author":"PM Phal","year":"2007","unstructured":"Phal PM, Myall RW, Assael LA, et\u00a0al. Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol 2007;28:1139\u201345","journal-title":"AJNR Am J Neuroradiol"},{"key":"33_CR23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejca.2006.12.006","volume":"43","author":"J-J Body","year":"2007","unstructured":"Body J-J, Coleman R, Clezardin P, et\u00a0al. International society of geriatric oncology (SIOG) clinical practice recommendation for the use of bisphosphonates in elderly patients. Eur J Cancer 2007;43:852\u20138","journal-title":"Eur J Cancer"},{"key":"33_CR24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.critrevonc.2006.12.005","volume":"62","author":"R Weitzman","year":"2007","unstructured":"Weitzman R, Sauter N, Eriksen EF, et\u00a0al. Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients-May 2006. Crit Rev Oncol Hematol 2007;62:148\u201352","journal-title":"Crit Rev Oncol Hematol"},{"key":"33_CR25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bone.2006.11.023","volume":"40","author":"C Dannemann","year":"2007","unstructured":"Dannemann C, Gratz KW, Riener MO, et\u00a0al. Jaw osteonecrosis related to bisphosphonates therapy. A severe secondary disorder. Bone 2007;40:828\u201334","journal-title":"Bone"},{"key":"33_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.mlg.0000187398.51857.3c","volume":"116","author":"MC Farrugia","year":"2006","unstructured":"Farrugia MC, Summerlin DJ, Krowiak E, et\u00a0al. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laringoscope 2006;116:115\u201320","journal-title":"Laringoscope"},{"key":"33_CR27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.tripleo.2006.10.010","volume":"103","author":"JK Brooks","year":"2007","unstructured":"Brooks JK, Gilson AJ, Sindler AG, et\u00a0al. Osteonecrosis of the jaws associated with use of risendronate: report of 2 new cases. Oral Sur Oral Med Oral Pathol 2007;103:780\u20136","journal-title":"Oral Sur Oral Med Oral Pathol"},{"key":"33_CR28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.14219\/jada.archive.2006.0350","volume":"137","author":"JB Nase","year":"2006","unstructured":"Nase JB, Suzuki JB. Osteonecrosis of the jaw and oral bisphosphonates treatment. J Am Dent Assoc 2006;137:1115\u20139","journal-title":"J Am Dent Assoc"},{"key":"33_CR29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.joms.2006.10.043","volume":"65","author":"FC Senel","year":"2007","unstructured":"Senel FC, Tekin US, Durmus A, et\u00a0al. Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonates (disodium clodronate): report of a case. J Oral Maxillofac Surg 2007;65:562\u20135","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0609.2007.00872.x","volume":"79","author":"AH Montazeri","year":"2007","unstructured":"Montazeri AH, Erskine JG, McQuaker IG. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma. Eur J Haematol 2007;79:69\u201371","journal-title":"Eur J Haematol"},{"issue":"10","key":"33_CR31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","volume":"18","author":"N Yarom","year":"2007","unstructured":"Yarom N, Yahalom Y, Shoshani, et\u00a0al. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 2007;18(10):1363\u201370","journal-title":"Osteoporos Int"},{"key":"33_CR32","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Barmias","year":"2005","unstructured":"Barmias A, Kastritis E, Bamia C, et\u00a0al. Ostenecrosis of the jaws in cancer after treatment bisphosphonates: incidence and risk factors. J Clin Oncol 2005;23:8580\u20137","journal-title":"J Clin Oncol"},{"key":"33_CR33","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","volume":"65","author":"EP Wang","year":"2007","unstructured":"Wang EP, Kaban LB, Strewler GJ, et\u00a0al. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 2007;65:1328\u201331","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","volume":"99","author":"GS Wilkinson","year":"2007","unstructured":"Wilkinson GS, Kuo Y-F, Freeman JL, et\u00a0al. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. J Natl Cancer Inst 2007;99:1016\u201324","journal-title":"J Natl Cancer Inst"},{"key":"33_CR35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bdj.4802906","volume":"133","author":"AE. Miles","year":"1972","unstructured":"Miles AE. Phosphorus necrosis of the jaw: \u201cphossy jaw\u201d. Br Dent J 1972;133:203\u20136","journal-title":"Br Dent J"},{"key":"33_CR36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","volume":"63","author":"JW Hellstein","year":"2005","unstructured":"Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 2005;63:682\u20139","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1079-2104(97)90287-0","volume":"84","author":"JK Wong","year":"1997","unstructured":"Wong JK, Wood RE, McClean M. Conservative management of osteoradionecrosis . Oral Surg Oral Med Oral Pathol 1997;84:16\u201321","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"33_CR38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1079-2104(97)90314-0","volume":"83","author":"J Epstein","year":"1997","unstructured":"Epstein J, van der Meij E, McKenzie M, et\u00a0al. Postradiation necrosis of the mandible: a long term follow-up study. Oral Surg Oral Med Oral Pathol 1997;83:657\u201362","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"33_CR39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hed.2890040313","volume":"4","author":"HC. Schwartz","year":"1982","unstructured":"Schwartz HC. Osteonecrosis of the jaws: a complication of cancer chemotherapy. Head Neck Surg 1982;4:251\u20133","journal-title":"Head Neck Surg"},{"key":"33_CR40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2141.2005.05833.x","volume":"132","author":"MN Polizzotto","year":"2006","unstructured":"Polizzotto MN, Cousins V, Schwarer AP. Bisphosphonate-associate osteonecrosis of the auditory canal. Br J Haematol 2006;132:114","journal-title":"Br J Haematol"},{"issue":"1","key":"33_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2006.12.003","volume":"37","author":"SL Silverman","year":"2007","unstructured":"Silverman SL, Maricic M. Recent developments in bisphosphonates therapy. Semin Arthritis Rheum 2007;37(1):1\u201312","journal-title":"Semin Arthritis Rheum"},{"key":"33_CR42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0714.2007.00540.x","volume":"36","author":"C Hewitt","year":"2007","unstructured":"Hewitt C, Farah CS. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med 2007;36:319\u201338","journal-title":"J Oral Pathol Med"},{"key":"33_CR43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","volume":"41","author":"IR Reid","year":"2007","unstructured":"Reid IR, Bolland MJ. Is bisphosphonates-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 2007;41:318\u201320","journal-title":"Bone"},{"key":"33_CR44","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.leu.2404682","volume":"21","author":"A Corso","year":"2007","unstructured":"Corso A, Varettoni M, Zappasodi P, et\u00a0al. A different schedule of zolendronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. Leukemia 2007;21:1545\u20138","journal-title":"Leukemia"},{"key":"33_CR45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","volume":"92","author":"M Kamaisi","year":"2006","unstructured":"Kamaisi M, Regegev E, Yarom N, et\u00a0al. Possible association between diabetes and bisphosphonates-related jaw osteonecrosis. J Clin Endocrinol Metab 2006;92:1172\u20135","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR46","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1469-0691.2006.01497.x","volume":"12","author":"A Tada","year":"2006","unstructured":"Tada A, Senpuku H, Motozawa Y, et\u00a0al. Association between commensal bacteria and opportunistic pathogens in the dental plaque of elderly individuals. Clin Microbiol Infect 2006;12:776\u201381","journal-title":"Clin Microbiol Infect"},{"key":"33_CR47","first-page":"347","volume-title":"Orthopaedic pathology","author":"P. Bullough","year":"2004","unstructured":"Bullough P. Osteonecrosis and bone infarction. In: Bullogh P, editor Orthopaedic pathology. 4th ed. Edinburgh: Mosby; 2004. p. 347\u201362","edition":"4"},{"key":"33_CR48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","volume":"35","author":"T Hansen","year":"2006","unstructured":"Hansen T, Kunkel M, Weber A, et\u00a0al. Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 2006; 35:155\u201360","journal-title":"J Oral Pathol Med"},{"key":"33_CR49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Wenkert D, Clements KL, et\u00a0al. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003;349:457\u201363","journal-title":"N Engl J Med"},{"key":"33_CR50","first-page":"269","volume":"364","author":"DP Lew","year":"2004","unstructured":"Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364:269\u201379","journal-title":"Lancet"},{"key":"33_CR51","first-page":"3537","volume":"85","author":"SL Greenspan","year":"2000","unstructured":"Greenspan SL, Rosen HN, Parker RA. Early changes in serum N-telepeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women. J Clin Endocrinol Metab 2000;85:3537\u201340","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR52","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/jor.20152","volume":"24","author":"T Schewelov von","year":"2006","unstructured":"von Schewelov T, Carlsson A, Dahlberg L. Cross-linked N-telopeptide of type I collagen (NTx) in urine as predictor of periprosthetic osteolysis. J Orthop Res 2006;24:1342\u20138","journal-title":"J Orthop Res"},{"key":"33_CR53","doi-asserted-by":"crossref","unstructured":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonates-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369\u201376","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"33_CR54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jbspin.2005.11.002","volume":"73","author":"A Naveau","year":"2006","unstructured":"Naveau A, Naveau B. Osteonecrosis of the jaw in patients taking bisphosphonates. Joint Bone Spine 2006;73:7\u20139","journal-title":"Joint Bone Spine"},{"key":"33_CR55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0b013e32819f820b","volume":"19","author":"T Wyngaert Van den","year":"2007","unstructured":"Van den Wyngaert T, Manon TU, Vermorken JB. Osteonecrosis of the jaw related to use of bisphosphonates. Curr Opin Oncol 2007;19:315\u201322","journal-title":"Curr Opin Oncol"},{"key":"33_CR56","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, et\u00a0al. Bisphosphonates-induced exposed bone of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567\u201375","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/MO:23:1:51","volume":"23","author":"SG Thakkar","year":"2006","unstructured":"Thakkar SG, Isada C, Smith J, et\u00a0al. Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias. Med Oncol 2006;23:51\u20136","journal-title":"Med Oncol"},{"key":"33_CR58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1601-0825.2005.01130.x","volume":"11","author":"FR Pires","year":"2005","unstructured":"Pires FR, Mirando A, Cardoso ES, et\u00a0al. Oral avascular bone necrosis associated with chemotherapy and bisphosphonate therapy. Oral Dis 2005;11:365\u20139","journal-title":"Oral Dis"},{"key":"33_CR59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tripleo.2007.01.008","volume":"104","author":"L Montebugnoli","year":"2007","unstructured":"Montebugnoli L, Felicetti L, Gissi B, et\u00a0al. Bisphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol 2007;104:473\u20137","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"33_CR60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","volume":"138","author":"MC Adornato","year":"2007","unstructured":"Adornato MC, Morcos I, Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 2007;138:971\u20137","journal-title":"J Am Dent Assoc"},{"key":"33_CR61","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.joms.2007.03.019","volume":"65","author":"JJ Freiberger","year":"2007","unstructured":"Freiberger JJ, Padilla-Burgos R, Chhoeu AH, et\u00a0al. Hyperbaric oxygen treatment and bisphosphonates-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 2007;65:1321\u20137","journal-title":"J Oral Maxillofac Surg"},{"key":"33_CR62","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/01.scs.0000249350.59096.d0","volume":"17","author":"A Agrillo","year":"2006","unstructured":"Agrillo A, Petrucci MT, Tedaldi M, et\u00a0al. New therapeutic protocol in the treatment of avascular necrosis of the jaws. J Cranio Surg 2006;17:1080\u20133","journal-title":"J Cranio Surg"},{"key":"33_CR63","doi-asserted-by":"crossref","unstructured":"Vescovi P, Merigo E, Meleti M, et\u00a0al. Nd:YAG laser biostimulation of bisphosphonateassociated necrosis of the jawbone with and without surgical treatment. Br J Oral Maxillofac Surg 2007); (electronic version-in press)","DOI":"10.1016\/j.bjoms.2007.03.016"},{"key":"33_CR64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1345\/aph.1H521","volume":"41","author":"CD Krueger","year":"2007","unstructured":"Krueger CD, West PM, Sargent M, et\u00a0al. Bisphosphonates-induced osteonecrosis of the jaws. Ann Pharmacother 2007;41:276\u201384","journal-title":"Ann Pharmacother"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-007-0033-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-007-0033-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-007-0033-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:06:09Z","timestamp":1559448369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-007-0033-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s12105-007-0033-2","relation":{},"ISSN":["1936-055X","1936-0568"],"issn-type":[{"value":"1936-055X","type":"print"},{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}